What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“Of the specialties offered at medical school, oncology is one of the most appealing options to me, due to my personal experiences as well as scientific appreciation for cancer. The feeling my family and I had after learning of my grandmother’s recovery from brain cancer is what I wish to give back to other families throughout my lifetime. I believe that CaNCURE will help me accomplish this goal with the thrill of scientific discovery.”

Jordan Harris, Chemical Engineering, ’17


Trainee Spotlight


Mahimasri Kotamreddy

Biology and Mathematics, '21

Understanding the Role of Epigenetics in Multiple Myeloma Progression

Muskaan Rastogi

Health Science, '21

Monocyte Subtype Determination by Labeling with Feraheme Nanoparticles

Rodrigo Blanco Bravo

Bioengineering, '22

Multiplexed cellular fluorescent imaging in head and neck squamous cell carcinomas (HNSCC) for different markers to predict patient specific response rates to immunotherapy and for mapping of the tumor microenvironment (TME).

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


Anne Klibanski, M.D.

Physician in Medicine,,

Studies the pathogenesis and hormone regulation of pituitary tumors, with the goal of identifying more effective therapies for endocrine tumor treatment. Students will have the opportunity to test and validate new therapeutic strategies in vitro, as well as analyze clinical trial data.


Kenneth Anderson,

Physician of Oncology ,

Focuses on translational research in multiple myeloma. Students will have the opportunity to characterize factors in the marrow microenvironment which allow tumor cell homing, growth and resistance to apoptosis in the marrow millieu in order to identify and validate next-generation novel small molecule and immune targeted therapies.


Trainee Spotlight


Mahimasri Kotamreddy

Biology and Mathematics, '21

Understanding the Role of Epigenetics in Multiple Myeloma Progression

Courtney Fraser

Health Science, '21

The Development and Characterization of Monoclonal Antibodies for Integrins and TGF-b

Marina Yamada

Health Science, '21

Triple-targeted Photonanomedicine: A Strategy to Treat Heterogeneous Tumors


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...